Cover Image
市場調查報告書

再灌流傷害:全球臨床實驗趨勢

Reperfusion Injury Global Clinical Trials Review, H2, 2016

出版商 GlobalData 商品編碼 244965
出版日期 內容資訊 英文 116 Pages
訂單完成後即時交付
價格
Back to Top
再灌流傷害:全球臨床實驗趨勢 Reperfusion Injury Global Clinical Trials Review, H2, 2016
出版日期: 2016年10月31日 內容資訊: 英文 116 Pages
簡介

本報告提供再灌流傷害相關之臨床研究最新趨勢分析,提供您疾病·治療方法概要,及G7、E7各國的臨床實驗狀況,各地區、各階段的進行狀況,彙整有潛力的贊助商,各企業及研究機關的研究進行狀況,有潛力的藥劑比較等資訊。

本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 前五名國家的臨床實驗數量; 亞太地區
    • 前五名國家的臨床實驗數量; 歐洲
    • 主要國家的臨床實驗數量; 北美
    • 主要國家的臨床實驗數量; 中東/非洲地區

G7各國的臨床實驗數量:再灌流傷害臨床實驗數量佔心臟血管臨床實驗數量比率

各期臨床實驗數量: G7各國

G7各國的臨床實驗數量:各期

E7各國的臨床實驗數量:再灌流傷害臨床實驗數量佔心臟血管臨床實驗數量比率

各期臨床實驗數量: E7各國

E7各國的臨床實驗數量:各期

各期臨床實驗數量

  • 各期的進展中臨床實驗數量

各進展狀況臨床實驗數量

評估項目別臨床實驗數量

一定期間所採用的受驗人數

贊助商類別的臨床實驗數量

有潛力的贊助商

臨床實驗主要參加企業 - 再灌流傷害治療藥

有潛力的藥劑

臨床實驗簡介的基本資料

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC3852CTIDB

GlobalData's clinical trial report, "Reperfusion Injury Global Clinical Trials Review, H2, 2016" provides an overview of Reperfusion Injury clinical trials scenario. This report provides top line data relating to the clinical trials on Reperfusion Injury. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
  • Top Five Countries Contributing to Clinical Trials in Europe 10
  • Top Countries Contributing to Clinical Trials in North America 11
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 12
  • Clinical Trials by G7 Countries: Proportion of Reperfusion Injury to Cardiovascular Clinical Trials 13
  • Clinical Trials by Phase in G7 Countries 14
  • Clinical Trials in G7 Countries by Trial Status 15
  • Clinical Trials by E7 Countries: Proportion of Reperfusion Injury to Cardiovascular Clinical Trials 16
  • Clinical Trials by Phase in E7 Countries 17
  • Clinical Trials in E7 Countries by Trial Status 18
  • Clinical Trials by Phase 19
  • In Progress Trials by Phase 20
  • Clinical Trials by Trial Status 21
  • Clinical Trials by End Point Status 22
  • Subjects Recruited Over a Period of Time 23
  • Clinical Trials by Sponsor Type 24
  • Prominent Sponsors 25
  • Top Companies Participating in Reperfusion Injury Therapeutics Clinical Trials 26
  • Prominent Drugs 28
  • Latest Clinical Trials News on Reperfusion Injury 29
  • Sep 23, 2016: Faraday Pharmaceuticals Announces First-In-Human Trial of FDY-5301 29
  • Clinical Trial Profile Snapshots 30

Appendix 113

  • Abbreviations 113
  • Definitions 113
  • Research Methodology 114
  • Secondary Research 114
  • About GlobalData 115
  • Contact Us 115
  • Disclaimer 115
  • Source 116

List of Tables

  • Reperfusion Injury Therapeutics, Global, Clinical Trials by Region, 2016* 6
  • Reperfusion Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
  • Reperfusion Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
  • Reperfusion Injury Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
  • Reperfusion Injury Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
  • Reperfusion Injury Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
  • Reperfusion Injury Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 12
  • Proportion of Reperfusion Injury to Cardiovascular Clinical Trials, G7 Countries (%), 2016* 13
  • Reperfusion Injury Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14
  • Reperfusion Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15
  • Proportion of Reperfusion Injury to Cardiovascular Clinical Trials, E7 Countries (%), 2016* 16
  • Reperfusion Injury Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17
  • Reperfusion Injury Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 18
  • Reperfusion Injury Therapeutics, Global, Clinical Trials by Phase, 2016* 19
  • Reperfusion Injury Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 20
  • Reperfusion Injury Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21
  • Reperfusion Injury Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22
  • Reperfusion Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23
  • Reperfusion Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 24
  • Reperfusion Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25
  • Reperfusion Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
  • Reperfusion Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28

List of Figures

  • Reperfusion Injury Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
  • Reperfusion Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
  • Reperfusion Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
  • Reperfusion Injury Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
  • Reperfusion Injury Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
  • Reperfusion Injury Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
  • Reperfusion Injury Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 12
  • Proportion of Reperfusion Injury to Cardiovascular Clinical Trials, G7 Countries (%), 2016* 13
  • Reperfusion Injury Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14
  • Reperfusion Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15
  • Proportion of Reperfusion Injury to Cardiovascular Clinical Trials, E7 Countries (%), 2016* 16
  • Reperfusion Injury Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17
  • Reperfusion Injury Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 18
  • Reperfusion Injury Therapeutics, Global, Clinical Trials by Phase (%), 2016* 19
  • Reperfusion Injury Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 20
  • Reperfusion Injury Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21
  • Reperfusion Injury Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22
  • Reperfusion Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23
  • Reperfusion Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 24
  • Reperfusion Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25
  • Reperfusion Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 26
  • Reperfusion Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28
  • GlobalData Methodology 114
Back to Top